ment is associated with increases in protein ~ynthesis,'~''' uptake of glucose," Na+, K+-ATPase activity,"." Na+/H+ exchange:' phosphatidylcholine turnover with diacylglycerol (DAG) prod~ction,~'~'~ protein kinase C (PKC) transloati ion,^^.'^ and activation of the RAF-1 proto-oncogene product.25, '6 Recent work has also shown that the M-CSF receptor is linked to a pertussis toxin-sensitive G protein.zO~'l In this regard, stimulation of Na+/H+ exchange as well as phosphatidylcholine hydrolysis and DAG production by M-CSF was inhibited by pertussis toXin.20, 21 The availability of a human cell line that expresses functional M-CSF receptors would provide a useful model to study the postreceptor effects of M-CSF. To date, investigations of M-CSF in human hematopoietic cells have been limited to the isolation of peripheral blood monocytes and the long-term culture of these cells is not possible. Another approach to studying M-CSF signaling pathways has used the transfection of c-fms expression vectors into certain cell
The present studies show that the human THP-1 myelomonocytic leukemia cell line,29330 but not HL-60 or U-937 cells, constitutively expresses the c-fms gene. We show that M-CSF bound to THP-1 cells is rapidly internalized and degraded intracellularly. Furthermore, we also provide evidence that treatment of THP-1 cells with M-CSF is associated with activation of PKC and induction of TNF gene expression.
nated to a specific activity of 2.6 X lo6 cpmlpmol protein. In some experiments, THP-1 cells were incubated in the presence of 100 ng/mL pertussis toxin (Sigma) for 18 hours before the addition of Ligand internalization and degradation of bound M-CSF was performed in triplicate on suspensions of THP-1 cells by a modification of a previously described method." THP-1 cells (106/assay) were exposed to 9 x 105 cpm of IzI-M-CSF for 3 hours at 4°C. The cells were washed three times with ice-cold RPMI 1640 medium containing 10% FBS, resuspended, and incubated at 37°C. Culture fluids were harvested at various times and treated with trichloroacetic acid to determine soluble '=I (representing degraded M-CSF). The cells were washed with ice-cold phosphate-buffered saline (PBS) and then incubated for 5 minutes at 4°C in 0.05 mol/L glycine-HC1 buffer (pH 2.3) containing 0.15 mol/L NaC1. After removal of the glycine buffer, cells were washed three times and solubilized with 2% sodium dodecyl sulfate (SDS). Radioactivity found in the glycine buffer represented surface bound M-CSF, while that in solubilized cells provided a measure of internalized Purified recombinant human M-CSF (rhM-CSF; Genetics Institute) in 0.1 mol/L NaH,CO,, pH 8.35, was biotinylated by incubation for 30 minutes with succinimidyl 6-(biotinamido)-hexanoate (Molecular Probes, Eugene, OR) at a protein:dye ratio of 1O:l. The biotinylated M-CSF was then extensively dialyzed against PBS, pH 7.2. To detect M-CSF receptors, cells were incubated with biotinylated M-CSF (0.5 FglmL) in staining buffer (PBS containing 2% FBS and 0.02% Na azide) for 45 minutes at 4°C. Cells were centrifuged at 50% for 5 minutes, washed once, and resuspended in 0.5 pg/mL of streptavidin-phycoerythrin (Molecular Probes). After incubation for 30 minutes at 4"C, cells were washed twice and fixed in PBS containing 0.5% paraformaldehyde. To show specificity of staining, control cells were incubated with 50 pg/mL (100-fold excess) of unlabeled M-CSF for 30 minutes at 4°C before the addition of biotinylated M-CSF. In experiments in which receptor internalization was assessed, cells were incubated with 0.5 Fg/mL of biotinylated M-CSF for 30 minutes at 37°C in staining buffer without Na azide to allow internalization to occur. After centrifugation, these cells were resuspended in staining buffer and analyzed by fluorescence-activated cell sorting.
THP-1 cells were suspended in serum-free RPMI 1640 medium and incubated in the presence of M-CSF at 37°C. The cells ( 107/assay) were collected, homogenized by passage through a 25-gauge needle, and immediately reconstituted in buffer A (20 mmol/L Tris-HC1, pH 7.5, 100 pg/mL aprotinin, 0.25 mmol/L leupeptin and 1 mmol/L phenylmethysulfonyl fluoride [PMSF] ). The cytosolic fraction was obtained following centrifugation, and the particulate fraction was solubilized in buffer A containing 1% Triton X-100 (Sigma) for 15 minutes on ice. PKC was purified by diethyl aminoethyl (DEAE)-cellulose column chromatography and elution with 80 mmol/L NaCl. Enzyme activity was assayed in 10 mmol/L MgCl,, 1 mmol/L CaCl,, lo6 CPM [y--"P]ATP (3,000 Ci/mmol; Amersham Corp, Arlington Heights, IL), 20 Fg histone H1, 8 pg/mL phosphatidylserine, and 11.7 nmol/L TPA. After incubation at 30°C for 10 minutes, PKC activity was determined by subtracting the amount of 32P incorporation into histone H1 in the absence of added phospholipids and calcium from that in the presence of these agents. Levels of PKC activity in the absence of calcium and phospholipid were less than 15% of the total activity.
Total cellular RNA was isolated by the guanidine isothiocyanate-cesium chloride technique as de~cribed.~'.'~ Total cellular RNA (10 to 20 M-CSF.
Measurement of "*I-M-CSF internalization and degradation.
M-CSF.
Detection of M-CSF receptor using biotinylated M-CSF.
PKC activation.
Preparation of RNA and Northern blot hybridization.
Fg) was subjected to electrophoresis in a 1% agarose/2.2 mol/L formaldehyde gel, transferred to nitrocellulose paper, and hybridized to one of the following "P-labeled DNA probes: (1) the 4.0-kb EcoRI fragment of a human c-fms cDNA"; (2) the 1.6-kb Pst I fragment of a human TNF cDNA purified from the pE4 plasmid"; and (3) the pAl plasmid containing a 2.0-kb Pst I insert of the chicken p-actin gene.36 The autoradiograms were scanned using an LKB Ultroscan XL laser densitometer (Bromma, Sweden) and analyzed using the Gelscan XL software package. The intensity of TNF hybridization was normalized against p-actin expression. THP-1 cells (lo8 cells per treatment) were washed with ice-cold PBS and the nuclei isolated by lysis in 0.5% NP-40 buffer as described." Nuclei were resuspended in glycerol buffer and incubated in an equal volume of reaction buffer containing 100 mmol/L KCl, 0.5 mmol/L each of ATP, GTP, and CTP, and 200 FCi [a-3ZP]UTP (800 Ci/mmol, New England Nuclear, Boston, MA) at 26°C for 30 minutes. The reaction was terminated by the addition of 100 p L of 10 mmol/L Tris-HC1 (pH 8.0), 1 mmol/L Na,EDTA, 100 mmol/L NaCl, 20 mmol/L MgCI,, 150 U/mL RNasin, and 40 pg/mL DNase and allowed to incubate at 28°C for 15 minutes. After proteinase K digestion, the RNA was extracted with phenol/chloroform/isoamyl alcohol (25241) and precipitated in ethanol and 2.5 mol/L ammonium acetate. The RNA was further purified by Sephadex G-50 column separation.
Plasmid DNAs containing various cloned inserts were digested with restriction endonucleases as follows: (1) the 2.0-kb Pst I fragment of the chicken @-actin pAl plasmid36 (positive control); (2) the 1.1-kb EamHI insert of the human P-globin gene3' (negative control); and (3) the EcoRI linearized human TNF cDNA from the pE4 plasmid. 35 The digested DNA was run in a 1% agarose gel and transferred to nitrocellulose filters by the method of Southern.
Run-on transcriptional analysis.
RESULTS
Expression of c-fms transcripts in human myelomonocytic leukemia cells. To determine if the c-fms gene is constitutively expressed in human myelomonocytic leukemia cell lines, we first performed Northern blot analysis of cellular RNA isolated from untreated HL-60, U-937, and THP-1 cells (Fig 1) . While c-jhs transcripts were undetectable in HL-60 and U-937 cells, specific hybridization of a 32P-labeled c-fms cDNA probe was found in THP-1 cells (Fig  1) . Normal human peripheral blood monocytes known to express the 4.8-kb c-fms transcripts were used as a positive control (Fig 1) .
Intemalization and degradation of M-CSF in THP-1 cells. We next studied the interaction of 'zI-labeled M-CSF with THP-1 cells. Incubation of THP-1 cells with 1251-labeled M-CSF resulted in rapid binding and then a progressive decline throughout 180 minutes of exposure. In contrast, '=I-M-CSF was rapidly internalized by THP-1 cells after 2.5 minutes at 37°C (Fig 2) . The increase in intracellular radioactivity peaked at 10 minutes and was followed by a decline. Furthermore, an increase in acid soluble (representing degraded lZI-M-CSF) was detectable by 30 minutes of exposure to '=I-M-CSF (Fig 2) . Taken receptors (Fig 3) . In contrast, M-CSF receptors were undetectable in HL-60 cells (Fig 3) . FACS analysis also showed that M-CSF receptors are detectable on 32D-c-fis cells, a mouse hematopoietic cell line transfected with a normal human c-fis gene" (Fig 3) . To assess internalization of the M-CSF receptor, THP-1 cells were incubated with biotinylated M-CSF at 37°C for 30 minutes before analysis. Under these conditions, FACS analysis showed that M-CSF receptor expression was undetectable, indicating that receptor internalization had occurred (data not shown).
Recent work has shown that treatment of human monocytes with M-CSF is associated with increased PKC acti~ity.".'~ We therefore Effects of M-CSF on PKC activation. monitored the activity of PKC in M-CSF-treated THP-1 cells. M-CSF treatment was associated with an increase in membrane-bound PKC and a decline in cytosolic enzyme activity (Fig 4) . This increase in membrane-bound PKC was maximal at 5 minutes of M-CSF exposure (Fig 4) . These findings indicated that M-CSF treatment of THP-1 cells is associated with the activation of PKC or a related enzyme.
Previous studies have shown that treatment of human monocytes with M-CSF results in an increase in TNF activity." The effects of M-CSF on TNF gene expression in THP-1 cells were studied by Northern blot analysis. The level of TNF transcripts increased 16-fold after 1 hour of exposure to M-CSF (Fig 5) . This increase was transient and the level of TNF transcripts returned to that in control cells by 24 hours (Fig 5) . M-CSF treatment had little effect on levels of actin transcripts (Fig 5) . Run For
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THP-1 cells with 100 ng/mL pertussis toxin inhibited M-CSF-induced increases in PKC activity. Membrane PKC activity was loo%, 104%, and 106% of basal levels after 2.5, 5, and 15 minutes of exposure to M-CSF in THP-1 cells pretreated with pertussis toxin, respectively. We also studied the effects of pretreatment of THP-1 cells with pertussis toxin on M-CSF-induced TNF gene expression. Pertussis toxin alone had no effect on TNF mRNA levels (Fig 7) . Furthermore, exposure of THP-1 cells to pertussis toxin failed to inhibit induction of TNF transcripts by M-CSF (Fig 7) . Taken together, these results suggest that the M-CSF-mediated increases in PKC activity involves a G protein-dependent mechanism and that this signaling pathway is independent of that involved with the induction of TNF mRNA.
Continuous exposure of cells to phorbol esters for prolonged periods of time is associated with downregulation of PKC activity?" The role of PKC in the induction of TNF by M-CSF was further examined by studying the effects of exposure to TPA for 36 hours. Exposure of THP-1 cells to TPA for 36 hours followed by treatment with M-CSF resulted in induction of TNF expression (Fig 8) . These results further support the findings that induction of TNF expression by M-CSF is independent of PKC activity in THP-I cells.
Previous studies have shown that treatment of THP-1 cells with TPA is associated with maturation into functional macrophages." Furthermore, c-fms mRNA is expressed in human monocvtes as well as during HL-60 myeloid differentiation."." Although TPA treatment is associated with a transient decrease in M-CSF receptors in human monocyte~,'~ prolonged exposure to TPA was associated with enhanced levels of c-fms transcripts in THP-1 cells (Fig 8) . Taken together, these results suggest that the increase in c-fms mRNA after TPA treatment in THP-1 cells is indicative of monocytic differentiation.
Effect of inhibitors of protein kinases on M-CSF-induced expression of TNF "A.
To determine whether protein kinases are involved in the regulation of TNF gene expression by M-CSF, we studied the effects of H-7, an isoquinolinesulfonamide derivative that inhibits PKC activity,40 on the regulation of M-CSF-induced TNF transcripts. Treatment of THP-1 cells with H-7 inhibited M-CSF-induced increases in TNF transcripts (Fig 9A) . In contrast, HA1004, M-CSF. A low but detectable level of TNF gene transcription was present in untreated THP-1 cells (Fig 6) . Furthermore, exposure to M-CSF for 1 hour increased TNF gene transcription by threefold (Fig 6) . Together with the above results, these findings show that M-CSF treatment of THP-1 cells is linked with at least two of the events associated with M-CSF signaling in human monocytes, PKC activation and induction of TNF transcripts.
Effect of pertussis toxin on M-CSF-induced PKC activity and TNF messenger RNA (mRNA). Recent work has shown that the M-CSF receptor is linked to a pertussis toxin-sensitive G protein.*".*' To determine whether a G protein is involved in M-CSF-induced signaling pathways in THP-I cells, we studied the effects of pertussis toxin on activation of PKC by M-CSF. Overnight pretreatment of a structurally related quinolone with more selective cGMPand CAMP-dependent protein kinase inhibitory activity:' failed to inhibit the effects of M-CSF on TNF gene expression (Fig 9A) . We also studied the'effects of staurosporine,4?4' a structurally distinct agent that inhibits protein kinase activity. Staurosporine alone had no effect on TNF gene expression (Fig 9B) . In contrast, staurosporine treatment of M-CSF-induced THP-1 cells blocked the expression of TNF RNA (Fig 9B) . Taken together, these results suggested that a protein kinase distinct from PKC may be involved in the regulation of TNF gene expression.
Effects of H-7 on the transcriptional and posttranscriptional regulation of TNF gene expression. Decreased levels of TNF mRNA in M-CSF-treated THP-1 cells exposed to H-7 could be related to inhibition of TNF transcription. However, treatment of THP-1 cells with M-CSF in the presence of H-7 failed to inhibit TNF gene transcription as compared with cells treated with M-CSF alone (data not shown). These findings suggested that decreased levels of TNF mRNA in THP-1 cells exposed to H-7 and M-CSF may result from decreased stabilization of the TNF transcript. To study posttranscriptional regulation of TNF mRNA, THP-1 cells were treated with M-CSF for 1 hour and then exposed to actinomycin-D in the absence or presence of H-7 for various times to inhibit transcription (Fig 10) . The half-life of TNF mRNA in the absence of a kinase inhibitor as determined by densitometric scanning was 13.4 5 2.5 minutes (Fig 10) . In contrast, the half-life of TNF mRNA in M-CSF-treated THP-1 cells exposed to H-7 and actinomycin-D was decreased to 5.6 5 0.3 minutes (Fig 10) . Because H-7 had no effect on the rates of TNF transcription as monitored by nuclear run-on assays, these findings suggested that the decrease in TNF mRNA observed during H-7 treatment is mediated by a posttranscriptional mechanism. Recent studies have shown that the M-CSF receptor is linked to a pertussis toxin-sensitive G protein.?"." Stimulation of Na'/H+ exchange as well as phosphatidylcholine hydrolysis and DAG production by M-CSF was inhibited by pertussis toxin.2"," The present studies similarly show that activation of PKC is inhibited by pertussis toxin. In contrast, the induction of T N F transcription by M-CSF was not blocked by pertussis toxin. Moreover, M-CSF treatment of THP-1 cells after prolonged TPA exposure was also associated with increases in T N F transcripts. These results suggest that at least two independent signaling pathways are involved in M-CSF-mediated events and that the induction of T N F by M-CSF is mediated by a PKCindependent mechanism. Although inhibition of PKC by pertussis toxin suggests the involvement of a G protein, pertussis toxin can elevate CAMP levels and block certain For personal use only. on November 11, 2017. by guest www.bloodjournal.org From specific kinase c-ruj2?5.26 as well as phosphatidylinositol-3 kinase," has implicated the involvement of other protein kinases in M-CSF-induced signaling events. Lastly, the demonstration that M-CSF-induced TNF expression is inhibited by H-7 and staurosporine suggests that an M-CSFactivated protein kinase may be sensitive to these agents.
The present results also show that M-CSF increases TNF mRNA levels by a transcriptional mechanism in THP-1 cells. The protein kinase inhibitors, H-7 and staurosporine, blocked the M-CSF-induced increases in TNF transcripts, but not the effects of M-CSF on activation of TNF gene transcription. These findings suggested that protein kinase activity may be involved in the regulation of TNF mRNA by a posttranscriptional mechanism. Indeed, the half-life of M-CSF-induced TNF mRNA in actinomycin D-treated THP-1 cells was 13.4 minutes, while inhibition of protein kinase decreased this half-life to 5.6 minutes. These results suggest that activation of a protein kinase by M-CSF is associated with stabilization of TNF transcripts.
Posttranscriptional mechanisms involving an AU-rich element in the 3' untranslated region are responsible for regulating the expressior. ; f : : ; : : i n protooncogenes and growth factor genes.",s5 Protein kinase-dependent pathways have been implicated in the stability of certain mRNAs. For example, previous studies have shown that IL-la and IL-lP are regulated posttranscriptionally by TPA in THp-1 c e k " Moreover, induction Of both C-fis and TNF gene expression by TPA is regulated by posttranscriptional mechanisms*5".s7
Lastly, recent studies have suggested that the dbility of TNF mRNA is regulated by a PKC-dependent pathway in Newcastle disease virus-stimulated astrocytes?' Identification of the mRNA sequence and RNA binding protein(s) involved in a protein kinase-dependent pathway may be helpful in understanding the M-CSF-induced signaling events that regulate gene expression. pathways by this cyclic n u c l e~t i d e .~~ However, there was no detectable increase in CAMP levels after exposure to pertussis toxin in human monocytes (M.L. Sherman et al, unpublished data). The recent finding that M-CSF treatment is associated with activation of the serine/threonine-
